Lifeward (LFWD) Other Non-Current Liabilities (2014 - 2026)
Lifeward (LFWD) reported Other Non-Current Liabilities of $54000.0 for Q1 2026, down 11.48% on a YoY basis from $61000.0 in Q1 2025, and down 11.48% sequentially from $61000.0 in Q4 2025.
Lifeward (LFWD) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Lifeward (LFWD) has 13 years of Other Non-Current Liabilities data on file, last reported at $54000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 11.48% year-over-year to $54000.0; the trailing twelve-month figure through Mar 2026 stood at $54000.0 (down 11.48% YoY), and the FY2025 full-year result was $61000.0, down 8.96% from the prior year.
- Other Non-Current Liabilities declined to $54000.0 in Q1 2026, from $61000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $387000.0 in Q3 2023 to a low of $13000.0 in Q2 2023.
- A 5-year average of $78470.6 and a median of $63000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 81.16% in 2023 and surged 584.62% in 2024, its largest moves.
- Tracing LFWD's Other Non-Current Liabilities over 5 years: stood at $66000.0 in 2022, then retreated by 12.12% to $58000.0 in 2023, then gained by 15.52% to $67000.0 in 2024, then dropped by 8.96% to $61000.0 in 2025, then slipped by 11.48% to $54000.0 in 2026.
- Business Quant data shows LFWD's Other Non-Current Liabilities at $54000.0 in Q1 2026, $61000.0 in Q4 2025, and $63000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 387,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 24,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 36,000.00 |